Literature DB >> 1617154

The role of cytokines in the pathogenesis of inflammatory eye disease.

D Wakefield1, A Lloyd.   

Abstract

A coherent view of the role of cytokines in inflammatory eye disease is emerging as a result of studies both in man and experimental animals. Cytokines have been demonstrated in ocular tissue obtained from patients with intraocular inflammation (uveitis) (gamma interferon, IL-2) and have been shown to induce inflammation in experimental animals after intraocular injection [(IL-1, IL-6, IL-8, tumour necrosis factor (TNF), granulocyte macrophage-colony stimulating factor (GM-CSF)]. Several unique features of the immunology of the eye such as the immunosuppression associated with anterior chamber associated immune deviation (ACAID) may be due to the effects of cytokines. Similarly, common complications of ocular inflammation such as glaucoma, keratic precipitates, retinal (macular) oedema and neovascularization may be mediated by cytokines. Understanding of the role of cytokines in inflammatory eye disease has the potential to lead to the development of therapies to abrogate the effects of these important mediators of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617154     DOI: 10.1016/1043-4666(92)90028-p

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  35 in total

1.  Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.

Authors:  J M des Grottes; M Schrooyen; J C Dumon; J J Body
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

3.  Local interferon alfa-2b for ocular cicatricial pemphigoid.

Authors:  M Gillies; I Francis; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

Review 4.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

Review 5.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Explorative study of interleukin levels in the human cornea.

Authors:  J Becker; S Salla; U Dohmen; C Redbrake; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

7.  Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation.

Authors:  Shallu Kutlehria; Imran Vhora; Arvind Bagde; Nusrat Chowdhury; Gautam Behl; Ketan Patel; Mandip Singh
Journal:  Pharm Res       Date:  2018-04-16       Impact factor: 4.200

8.  Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.

Authors:  Gabriel Sosne; Ping Qiu; Michelle Kurpakus-Wheater
Journal:  Clin Ophthalmol       Date:  2007-09

Review 9.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

10.  Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Clin Diagn Lab Immunol       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.